Cat.#: ACPP-1243
| Despition | ELOVL4 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1154 | Recombinant Human FGF19 Protein (6×His Tag) (AC1154) | 50 µg | inquiry |
| ACPP-1771 | Human ATG3 Protein (AC1771) | 5 µg | inquiry |
| ACPP-1050 | Recombinant Human LIF Protein (Fc Tag) (AC1050) | 50 µg | inquiry |
| ACPP-1749 | Human CSNK1D Protein (AC1749) | 5 µg | inquiry |
| ACPP-1411 | Human NDEL1 Protein (AC1411) | 2 µg | inquiry |
| ACPP-1416 | Human VAMP1 Protein (AC1416) | 20 µg | inquiry |
| ACPP-1193 | Human M2 Protein (AC1193) | 5 µg | inquiry |
| ACPP-1694 | Mouse FGF 1 Protein, His (AC1694) | 5 µg | inquiry |
| ACPP-1067 | Recombinant Human CD11b Protein (Fc Tag) (AC1067) | 50 µg | inquiry |
| ACPP-1844 | Human GCLM Protein (AC1844) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.